DGS Capital Management LLC Has $1.80 Million Stock Position in Intuitive Surgical, Inc. $ISRG

DGS Capital Management LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 184.7% in the fourth quarter, HoldingsChannel reports. The firm owned 3,183 shares of the medical equipment provider’s stock after purchasing an additional 2,065 shares during the period. DGS Capital Management LLC’s holdings in Intuitive Surgical were worth $1,803,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. SG Trading Solutions LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $1,359,000. Kera Capital Partners Inc. grew its position in shares of Intuitive Surgical by 47.7% during the 4th quarter. Kera Capital Partners Inc. now owns 1,037 shares of the medical equipment provider’s stock worth $587,000 after buying an additional 335 shares during the period. MV Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $300,000. Continental Investors Services Inc. increased its stake in shares of Intuitive Surgical by 8.0% in the 4th quarter. Continental Investors Services Inc. now owns 594 shares of the medical equipment provider’s stock valued at $336,000 after acquiring an additional 44 shares in the last quarter. Finally, Cambient Family Office LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $10,164,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This trade represents a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock worth $3,059,135 in the last quarter. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research note on Wednesday, May 27th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Bank of America cut their price objective on shares of Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $580.00 target price on shares of Intuitive Surgical in a research report on Tuesday, June 2nd. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $573.42.

Intuitive Surgical Trading Up 1.1%

ISRG opened at $406.78 on Friday. Intuitive Surgical, Inc. has a 1-year low of $396.68 and a 1-year high of $603.88. The company has a market cap of $144.07 billion, a price-to-earnings ratio of 49.31, a PEG ratio of 3.27 and a beta of 1.46. The company’s fifty day moving average price is $439.54 and its two-hundred day moving average price is $491.05.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s revenue was up 23.0% on a year-over-year basis. During the same period last year, the company earned $1.81 earnings per share. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.